Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.

Devalingam Mahalingam,Salih Hanni,Anthony V Serritella,Christos Fountzilas,Joel Michalek,Brian Hernandez,John Sarantopoulos,Paromitta Datta,Ofelia Romero,Sureshkumar Mulampurath Achutan Pillai,John Kuhn,Michael Pollak,Ian M Thompson

Oncotarget（2023）

Cited 0|Views17
No score
Abstract
In our small study, metformin added to ADT did not show a reduced risk of ADT-related MS or differences in PSA response.
More
Translated text
Key words
metformin,advanced prostate cancer,prostate cancer,metabolic syndrome,non-diabetic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined